Executive record
Tibor Keler, Ph.D.
Executive Vice President and Chief Scientific Officer at Celldex Therapeutics, Inc.
More
Alpha ID: alpha:person:tibor-keler-ph-dVersion: public-0As of: 2026-10-03
- Executive
Leadership, in context.
Connect capital, control, accountability, and evidence.
Explore the record
ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.Key Claims
Board service
Board service coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageExecutive career
- Current · dates not publishedExecutive Vice President and Chief Scientific Officer · Celldex Therapeutics, Inc.
- Dates not publishedExecutive title: Executive Vice President and Chief Scientific Officer · Organization not published
Claims
Compensation
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageConflicts and accountability
Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
Evidence, history and coverage
Published evidence records
1 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
Open source
sec def 14a · Source published: Apr 29, 2026 · Retrieved: Sep 6, 2026
Supports 2 claims
- Professional Role: Executive Vice President and Chief Scientific Officer at Celldex Therapeutics, Inc. · Claim reviewed: Sep 6, 2026
- Executive title: Executive title: Executive Vice President and Chief Scientific Officer · Claim reviewed: Sep 6, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-03
- Biography
- not observed
- Board service
- not observed
- Executive career
- published
- Education and qualifications
- not observed
- Compensation
- not observed
- Conflicts and accountability
- not observed
- Background screening
- out of scope